The genomics of oral cancer and wound healing

Journal of Indian Society of Pedodontics and Preventive Dentistry

Volumn 27, Issue 1, 2009, Pages 2-5

  Aswini, Y B ^a  

^a Research Center   (India)

Author keywords

Gene therapy; Genetic screening; Genetics; Oral cancer; Wound healing

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MOUTH TUMOR; MUTATION; ONCOGENE; PAPILLOMA VIRUS; PATHOGENICITY; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VIROLOGY; WOUND HEALING;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOUTH NEOPLASMS; MUTATION; NF-KAPPA B; ONCOGENES; PAPILLOMAVIRIDAE; WOUND HEALING;

EID: 68949207047     PISSN: 09704388     EISSN: 19983905     Source Type: Journal    
DOI: 10.4103/0970-4388.50808     Document Type: Conference Paper

References (38)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-94.
2. Paul H. Oral cancer molecular genetics. Available from: http://www.beatson.gla.ac.uk/research/index.html?topic-id=272/12/08.
3. Pavanello S, Clonfero E. Biological indicators of genotoxic risk and metabolic polymorphisms. Mutat Res 2000;463:285-308.
4. Friedlander PL. Genomic instability in head and neck cancer patients. Head Neck 2001;23:683-91.
5. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kB. J Clin Investig 2001;107:241-6.
6. Sato M, Sato T, Izumo T, Amagasa T. Genetic polymorphism of drug metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 1999;20:1927-31.
7. Slavkin HC. Human genome, implications for oral health and diseases and dental education. J Dent Edu 2001;65:463-79.
8. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between HPV and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20.
9. Steenbergen RD, Hermsen MA, Walboomers JM, Joenje H, Arwert F, Meijer CJ, et al. Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 1995;55:5465-71.
10. Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH, Haugen TH, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004;96:449-55.
11. Franceschi S, Munoz N, Snijders PJ. How strong and how wide is the link between HPV and oropharyngial cancer? Lancet 2000;356:871-2.
12. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, et al. Etiological involvment of oncogenic HPV in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998;58:5-13.
13. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX. Involvement of intact HPV 16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002;21:1510-7.
14. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001;93:232-5.
15. Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH. Human papillomavirus and risk of oral cancer. Laryngoscope 1998;108:1098-103.
16. Wong M, Pagano JS, Schiller JT, Tevethia SS, Raab-Traub N, Gruber J. New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer. J Natl Cancer Inst 2002;94:1832-6.
17. Anderson JA, Irish JC, McCachlin CM, Ngan BY. H-ras ongogene mutation and human papillomavirus infection in oral carcinomas. Arch Otolaryngol Head Neck Surg 1994;120:755-60.
18. Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU, et al. Human papillomaviruses in 91 oral cancers from Indian betel quid chewers-high prevalence and multiplicity of infections. Int J Cancer 1995;61:450-4.
19. Katiyar S, Thelma BK, Murthy NS, Hedau S, Jain N, Gopalkrishna V, et al. Polymorphism of the p53 codon 72 Arg/ Pro and the risk of HPV type 16/18- associated cervical and oral cancer in India. Mol Cell Biochem 2003;252:117-22.
20. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: A meta analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:622-35.
21. Misra C, Majumder M, Bajaj S, Ghosh S, Roy B, Roychoudhury S. Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer. Mol Carcinog 2009 Feb 9.
22. Newton TR, Patel NM, Bhatt-Nakshatri P, Stauss CR, Goulet RJ Jr, Nakshatri H. Negative regulation of transactivation function but not DNA binding of NF-jB and AP-1 by IjBb1 in breast cancer cells. J Biol Chem 1999;274:18827-35.
23. Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT. Mutations in the IjBa gene in Hodgkin's disease suggest a tumour suppressor role for IjBa. Oncogene 1999;18:3063-70.
24. Nair S, Pillai MR. Human papillomavirus and disease mechanisms: Relevance to oral and cervical cancers. Oral Dis 2005;11:350-9.
25. Tsui IF, Rosin MP, Zhang L, Ng RT, Lam WL. Multiple aberrations of chromosome 3p detected in oral premalignant lesions. Cancer Prev Res (Phila Pa) 2008;1:424-9.
26. Clark RA. Cutaneous tissue repair: Basic biological consideration, I. J Am Acad Dermatol 1985;13:701-25.
27. Arnold F, West DC. Angiogenesis in wound healing. Pharmacol Ther 1991;52:407-22.
28. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-4.
29. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992;176:1375-9.
30. Ansel JC, Tiesman JP, Olerud JE, Krueger JG, Krane JF, Tara DC, et al. Human keratinocytes are a major source of cutaneous platelet-derived growth factor. J Clin Investig 1993;92:671-8.
31. Galeano M, Altavilla D, Cucinotta D, Russo GT, Calò M, Bitto A, et al. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 2004;53:2509-17.
32. Roberts AB. Transforming growth factor-b: Activity and efficacy in animal models of wound healing. Wound Repair Regen 1995;3:408-18.
33. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JJ, Mizel DE, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Cell Biol 1999;1: 26.
34. Gotoh A, Kao C, Ko SC, Hamada K, Liu TJ, Chung LW. Cytotoxic effects of recombinant adenovirus P53 and cycle regulators genes (p21 and p16) in human prostate cancer. J Urol 1997;158:636-41.
35. Gleich LL. Gene therapy for head and neck cancer. Laryngoscope 2000;110:708-26.
36. 53 molecule and its prognostic role in squamous cel carcinoma of teh head and neck. J Oral Pathol Med 2000;29:413-25.
37. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1998;242:1528-34.
38. Garcia-Godoy F. Tissue engineering. Dent Clin North Am 2006;50:157-299.